Pipeline preview.
- Published in:
- Formulary, 2007, v. 42, n. 6, p. 359
- Publication type:
- Article
Works matching DE "DENDREON Corp."
Results: 25
1
2
Product Preview.
- Published in:
- 2007
- Publication type:
- Product Review
3
Product Preview.
- Published in:
- Urology Times, 2006, v. 34, n. 12, p. 27
- Publication type:
- Article
4
Product Preview.
- Published in:
- Urology Times, 2006, v. 34, n. 1, p. 36
- Publication type:
- Article
5
Product Preview.
- Published in:
- Urology Times, 2005, v. 33, n. 13, p. 36
- Publication type:
- Article
6
A shot in the arm for cancer vaccines?
- Published in:
- Nature, 2010, v. 464, n. 7292, p. 1110, doi. 10.1038/4641110a
- By:
- Publication type:
- Article
7
News Briefs on Prostate Cancer, Alcoholism, Osteoporosis, and Drug Updates.
- Published in:
- Urologic Nursing, 2005, v. 25, n. 6, p. 481
- By:
- Publication type:
- Article
8
From the Editor-in-Chief.
- Published in:
- BioProcessing Journal, 2015, v. 14, n. 1, p. 5
- By:
- Publication type:
- Article
9
From the Publisher.
- Published in:
- BioProcessing Journal, 2010, v. 9, n. 2, p. 3
- By:
- Publication type:
- Article
10
Companies ponder how truly 'personal' medicines can get.
- Published in:
- Nature Medicine, 2011, v. 17, n. 5, p. 519, doi. 10.1038/nm0511-519
- By:
- Publication type:
- Article
11
Despite steep costs, payments for new cancer drugs make economic sense.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
12
Therapeutic cancer vaccine survives biotech bust.
- Published in:
- Nature, 2015, v. 519, n. 7541, p. 17, doi. 10.1038/nature.2015.16990
- By:
- Publication type:
- Article
13
David Urdal. Interview with Asher Mullard.
- Published in:
- 2011
- Publication type:
- Interview
14
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 921, doi. 10.1038/nrd3071
- Publication type:
- Article
15
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 5, p. 346, doi. 10.1038/nrd2895
- Publication type:
- Article
16
Business News.
- Published in:
- Applied Clinical Trials, 2003, v. 12, n. 4, p. 60
- Publication type:
- Article
17
Dendreon bankrupt.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 12, p. 1176, doi. 10.1038/nbt1214-1176a
- Publication type:
- Article
18
Active Immunotherapy for Prostate Cancer.
- Published in:
- AUANews, 2008, v. 13, n. 3, p. 22
- By:
- Publication type:
- Article
19
What Happened to Provenge in the FDA Approval Process and Where Do We Go Now?
- Published in:
- 2007
- By:
- Publication type:
- Editorial
20
First cancer vaccine could give men with prostate cancer a better chance of survival.
- Published in:
- Chemistry & Industry, 2005, n. 5, p. 10
- By:
- Publication type:
- Article
21
Designer lymphocytes to fight cancer: a helping hand from modern molecular biology.
- Published in:
- Journal of Molecular Medicine, 2010, v. 88, n. 11, p. 1081, doi. 10.1007/s00109-010-0682-6
- By:
- Publication type:
- Article
22
Market watch.
- Published in:
- Nature, 2007, v. 448, n. 7150, p. 121, doi. 10.1038/448121b
- Publication type:
- Article
23
Provenge twists again.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 9, p. 882, doi. 10.1038/nbt0910-882a
- By:
- Publication type:
- Article
24
An empiric victory.
- Published in:
- 2010
- Publication type:
- Editorial
25
Announcements.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 7, p. 880
- Publication type:
- Article